Trial Profile
A Phase I Study of IBsolvMIR (dextran sulfate-low molecular weight) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Sep 2014
Price :
$35
*
At a glance
- Drugs Dextran sulfate (Primary)
- Indications Haematological malignancies; Pancreas transplant rejection
- Focus Adverse reactions
- Sponsors TikoMed
- 02 Sep 2014 New trial record